Nadav Kidron - 28 Jul 2022 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
President and CEO, Director
Signature
/s/ Nadav Kidron
Issuer symbol
ORMP
Transactions as of
28 Jul 2022
Net transactions value
-$105,595
Form type
4
Filing time
01 Aug 2022, 20:00:49 UTC
Previous filing
11 Jan 2022
Next filing
28 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +34,000 +3.7% 964,729 28 Jul 2022 Direct F1
transaction ORMP Common Stock Award +126,000 +13% 1,090,729 28 Jul 2022 Direct F2
transaction ORMP Common Stock Tax liability $105,595 -12,631 -1.2% $8.36 1,078,098 01 Aug 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Common Stock granted by the Issuer that vested on August 1, 2022.
F2 Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 42,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
F3 Payment of tax liability by withholding securities related to the 34,000 shares of Common Stock granted on July 28, 2022.